EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment.
*sb0459*
SENATE BILL 459
J1, J2, F5 5lr3037
CF HB 420
By: Senator Gile
Introduced and read first time: January 21, 2025
Assigned to: Finance and Education, Energy, and the Environment
Committee Report: Favorable
Senate action: Adopted
Read second time: February 11, 2025
CHAPTER ______
AN ACT concerning 1
Education and Health – Emergency Use Epinephrine – Alterations 2
FOR the purpose of altering the defined term “auto–injectable epinephrine” to be 3
“emergency use epinephrine” and to include certain drug delivery devices and 4
products; altering the name of the Emergency Use Auto–Injectable Epinephrine 5
Program to be the Emergency Use Epinephrine Program; and generally relating to 6
emergency use epinephrine. 7
BY repealing and reenacting, with amendments, 8
Article – Education 9
Section 7–426.2, 7–426.3, and 9.5–117(a)(3) and (f) 10
Annotated Code of Maryland 11
(2022 Replacement Volume and 2024 Supplement) 12
BY repealing and reenacting, without amendments, 13
Article – Education 14
Section 9.5–117(a)(1) 15
Annotated Code of Maryland 16
(2022 Replacement Volume and 2024 Supplement) 17
BY repealing and reenacting, with amendments, 18
Article – Health – General 19
Section 13–702, 13–704(e), 13–705, 13–706(a), 13–707(a) and (b), and 13–708(b); and 20
13–7A–01, 13–7A–02, 13–7A–03(a)(5), 13–7A–06, 13–7A–07(a) and (b), 21 2 SENATE BILL 459
13–7A–08(b), and 13–7A–09 to be under the amended subtitle “Subtitle 7A. 1
Emergency Use Epinephrine Program” 2
Annotated Code of Maryland 3
(2023 Replacement Volume and 2024 Supplement) 4
BY repealing and reenacting, without amendments, 5
Article – Health Occupations 6
Section 14–5F–01(a) and 14–5F–04.1(a)(1) 7
Annotated Code of Maryland 8
(2021 Replacement Volume and 2024 Supplement) 9
BY repealing 10
Article – Health Occupations 11
Section 14–5F–01(c) 12
Annotated Code of Maryland 13
(2021 Replacement Volume and 2024 Supplement) 14
BY repealing and reenacting, with amendments, 15
Article – Health Occupations 16
Section 14–5F–01(d) through (g), 14–5F–04.1(d)(1), and 14–5F–14(a)(5) 17
Annotated Code of Maryland 18
(2021 Replacement Volume and 2024 Supplement) 19
BY adding to 20
Article – Health Occupations 21
Section 14–5F–01(g) 22
Annotated Code of Maryland 23
(2021 Replacement Volume and 2024 Supplement) 24
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25
That the Laws of Maryland read as follows: 26
Article – Education 27
7–426.2. 28
(a) (1) In this section the following words have the meanings indicated. 29
(2) “Anaphylaxis” means a sudden, severe, and potentially life–threatening 30
allergic reaction that occurs when an individual is exposed to an allergen. 31
(3) [“Auto–injectable] “EMERGENCY USE epinephrine” means a portable, 32
disposable drug delivery device OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 33
DRUG ADMINISTRATION that contains a premeasured single dose of epinephrine that is 34
used to treat anaphylaxis in an emergency situation. 35
SENATE BILL 459 3
(b) Each county board shall establish a policy for public schools within its 1
jurisdiction to authorize the school nurse and other school personnel to administer 2
[auto–injectable] EMERGENCY USE epinephrine, if available, to a student who is 3
determined to be or perceived to be in anaphylaxis, regardless of whether the student: 4
(1) Has been identified as having an anaphylactic allergy, as defined in § 5
7–426.1 of this subtitle; or 6
(2) Has a prescription for epinephrine as prescribed by an authorized 7
licensed health care practitioner under the Health Occupations Article. 8
(c) The policy established under subsection (b) of this section shall include: 9
(1) Training for school personnel on how to recognize the symptoms of 10
anaphylaxis; 11
(2) Procedures for the emergency administration of [auto–injectable] 12
EMERGENCY USE epinephrine; 13
(3) The proper follow–up emergency procedures; 14
(4) A provision authorizing a school nurse to obtain and store at a public 15
school [auto–injectable] EMERGENCY USE epinephrine to be used in an emergency 16
situation; and 17
(5) A requirement that each public school develop and implement a method 18
for notifying the parents or guardians of students of the school’s policy under this section 19
at the beginning of each school year. 20
(d) Except for any willful or grossly negligent act, a school nurse or other school 21
personnel who respond in good faith to the anaphylactic reaction of a child in accordance 22
with this section may not be held personally liable for any act or omission in the course of 23
responding to the reaction. 24
(e) (1) Each public school shall submit, on the form that the Department 25
requires, a report to the Department on each incident at the school or at a related school 26
event that required the use of [auto–injectable] EMERGENCY USE epinephrine. 27
(2) The Department shall develop and disseminate a standard form to 28
report each incident requiring the use of [auto–injectable] EMERGENCY USE epinephrine 29
at a public school. 30
7–426.3. 31
(a) (1) In this section the following words have the meanings indicated. 32
4 SENATE BILL 459
(2) “Anaphylaxis” means a sudden, severe, and potentially life–threatening 1
allergic reaction that occurs when an individual is exposed to an allergen. 2
(3) [“Auto–injectable] “EMERGENCY USE epinephrine” means a portable, 3
disposable drug delivery device OR PRODUCT APPROVED BY THE FEDE RAL FOOD AND 4
DRUG ADMINISTRATION that contains a premeasured single dose of epinephrine that is 5
used to treat anaphylaxis in an emergency situation. 6
(4) “School personnel” means individuals who are employed by a nonpublic 7
school, including part–time employees, teachers and substitute teachers employed by the 8
school for at least 7 days each school year, a school nurse, registered nurse case manager, 9
delegating nurse, and administrative staff. 10
(b) Each nonpublic school in the State may establish a policy authorizing school 11
personnel to administer [auto–injectable] EMERGENCY USE epinephrine, if available, to a 12
student who is determined to be or perceived to be in anaphylaxis, regardless of whether 13
the student: 14
(1) Has been identified as having an anaphylactic allergy, as defined in § 15
7–426.1 of this subtitle; or 16
(2) Has a prescription for epinephrine as prescribed by an authorized 17
licensed health care practitioner under the Health Occupations Article. 18
(c) The policy established under subsection (b) of this section shall include: 19
(1) Training for school personnel on how to recognize the signs and 20
symptoms of anaphylaxis by a licensed health care practitioner who is authorized to 21
administer [auto–injectable] EMERGENCY USE epinephrine and who has been trained in 22
an established protocol on how to recognize the signs and symptoms of anaphylaxis; 23
(2) Procedures for the emergency administration of [auto–injectable] 24
EMERGENCY USE epinephrine; 25
(3) The proper follow–up emergency procedures; 26
(4) A provision authorizing a school nurse or other licensed health care 27
practitioner to obtain, and[,] school personnel to store, at a nonpublic school 28
[auto–injectable] EMERGENCY USE epinephrine to be used in an emergency situation; 29
(5) A requirement that the nonpublic school develop and implement a 30
method for notifying the parents or guardians of students of the school’s policy under this 31
section at the beginning of each school year; and 32
SENATE BILL 459 5
(6) An ongoing process for oversight and monitoring by a licensed health 1
care practitioner of the implementation of the policy established under subsection (b) of this 2
section. 3
(d) Except for any willful or grossly negligent act, school personnel who respond 4
in good faith to the anaphylactic reaction of a child in accordance with this section may not 5
be held personally liable for any act or omission in the course of responding to the reaction. 6
9.5–117. 7
(a) (1) In this section the following words have the meanings indicated. 8
(3) [“Auto–injectable] “EMERGENCY USE epinephrine” has the meaning 9
stated in § 7–426.2 of this article. 10
(f) Except for any willfully or grossly negligent act, a child care provider or an 11
employee of a child care provider who responds in good faith to the anaphylactic reaction 12
of a child in accordance with the guidelines implemented under this section or by use of 13
[auto–injectable] EMERGENCY USE epinephrine is immune from civil liability for any act 14
or omission in the course of responding to the reaction. 15
Article – Health – General 16
13–702. 17
(a) In this subtitle the following words have the meanings indicated. 18
(b) “Agent” means an individual who: 19
(1) Is at least 18 years of age; 20
(2) Has successfully completed, at the expense of an applicant, an 21
educational training program approved by the Department; and 22
(3) Is appointed by a certificate holder to administer [auto–injectable] 23
EMERGENCY USE epinephrine in accordance with the provisions of this subtitle. 24
(c) “Anaphylaxis” means a sudden, severe, and potentially life–threatening 25
allergic reaction that occurs when an individual is exposed to an allergen. 26
[(d) “Auto–injectable epinephrine” means a portable, disposable drug delivery 27
device that contains a premeasured single dose of epinephrine that is used to treat 28
anaphylaxis in an emergency situation.] 29
[(e)] (D) “Certificate” means a certificate or an endorsement on the operating 30
certificate of a youth camp issued by the Department to an individual who operates a youth 31 6 SENATE BILL 459
camp under Title 14, Subtitle 4 of this article to obtain, store, and administer 1
[auto–injectable] EMERGENCY USE epinephrine. 2
[(f)] (E) “Certificate holder” means an individual who is authorized by the 3
Department to obtain, store, and administer [auto–injectable] EMERGENCY USE 4
epinephrine to be used in an emergency situation. 5
(F) “EMERGENCY USE EPI NEPHRINE” MEANS A PORTABLE , DISPOSABLE 6
DRUG DELIVERY DEVICE OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 7
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 8
EPINEPHRINE THAT IS USED TO TREAT ANAPHY LAXIS IN AN EMERGENC Y SITUATION. 9
(g) “Program” means the Emergency and Allergy Treatment Program. 10
(h) “Registered nurse practitioner” has the meaning stated in § 8–101 of the 11
Health Occupations Article. 12
(i) “Youth camp” has the meaning stated in § 14–401 of this article. 13
13–704. 14
(e) An applicant shall have a written policy that includes: 15
(1) Authorization for the certificate holder or agent to administer 16
[auto–injectable] EMERGENCY USE epinephrine, if available, to an individual who has 17
been determined to be or is believed to be experiencing anaphylaxis, whether or not the 18
individual: 19
(i) Has previously been known to have experienced anaphylaxis; or 20
(ii) Has a prescription for epinephrine prescribed by an authorized 21
health care practitioner licensed under the Health Occupations Article; 22
(2) A requirement that youth camp personnel complete training on how to 23
recognize the symptoms of anaphylaxis; 24
(3) Procedures for the emergency administration of [auto–injectable] 25
EMERGENCY USE epinephrine; 26
(4) Procedures for proper emergency follow–up; 27
(5) Authorization for a certificate holder to obtain and store 28
[auto–injectable] EMERGENCY USE epinephrine to be used in an emergency; and 29
SENATE BILL 459 7
(6) A requirement that each certificate holder implement a method for 1
notifying the parent or guardian of a camper of the youth camp’s policy under this section 2
before the camper’s attendance. 3
13–705. 4
(a) (1) A registered nurse practitioner or a physician licensed to practice 5
medicine in the State may prescribe [auto–injectable] EMERGENCY USE epinephrine in 6
the name of a certificate holder. 7
(2) A registered nurse practitioner, a pharmacist licensed to practice 8
pharmacy in the State, or a physician may dispense [auto–injectable] EMERGENCY USE 9
epinephrine under a prescription issued to a certificate holder. 10
(b) A certificate holder may: 11
(1) On presentment of a certificate, receive from any registered nurse 12
practitioner or any physician licensed to practice medicine in the State a prescription for 13
[auto–injectable] EMERGENCY USE epinephrine and the necessary paraphernalia for the 14
administration of [auto–injectable] EMERGENCY USE epinephrine; and 15
(2) Possess and store prescribed [auto–injectable] EMERGENCY USE 16
epinephrine and the necessary paraphernalia for the administration of [auto–injectable] 17
EMERGENCY USE epinephrine. 18
(c) In an emergency situation when registered nurse practitioner, physician, or 19
emergency medical services are not immediately available, a certificate holder or agent may 20
administer [auto–injectable] EMERGENCY USE epinephrine to an individual who is 21
experiencing or believed in good faith by the certificate holder or agent to be experiencing 22
anaphylaxis. 23
13–706. 24
(a) A certificate holder shall submit to the Department, on a form required by the 25
Department, a report of each incident that occurs while the youth camp is in session that 26
required the administration of [auto–injectable] EMERGENCY USE epinephrine. 27
13–707. 28
(a) A cause of action may not arise against a certificate holder or agent authorized 29
under this subtitle for any act or omission when the certificate holder or agent is acting in 30
good faith while administering [auto–injectable] EMERGENCY USE epinephrine to an 31
individual experiencing or believed by the certificate holder or agent to be experiencing 32
anaphylaxis, except where the conduct of the certificate holder or agent amounts to gross 33
negligence, willful or wanton misconduct, or intentionally tortious conduct. 34
8 SENATE BILL 459
(b) (1) A cause of action may not arise against any physician for any act or 1
omission when the physician in good faith prescribes or dispenses [auto–injectable] 2
EMERGENCY USE epinephrine and the necessary paraphernalia for the administration of 3
[auto–injectable] EMERGENCY USE epinephrine to a person certified by the Department 4
under this subtitle. 5
(2) A cause of action may not arise against any pharmacist for any act or 6
omission when the pharmacist in good faith dispenses [auto–injectable] EMERGENCY USE 7
epinephrine and the necessary paraphernalia for the administration of [auto–injectable] 8
EMERGENCY USE epinephrine to a person certified by the Department under this subtitle. 9
(3) A cause of action may not arise against any nurse practitioner for any 10
act or omission when the nurse practitioner in good faith prescribes or dispenses 11
[auto–injectable] EMERGENCY USE epinephrine and the necessary paraphernalia for the 12
administration of [auto–injectable] EMERGENCY USE epinephrine to a person certified by 13
the Department under this subtitle. 14
13–708. 15
(b) An individual may not be held civilly liable in any action arising from or in 16
connection with the administration of [auto–injectable] EMERGENCY USE epinephrine by 17
the individual solely because the individual did not possess a certificate issued under this 18
subtitle. 19
Subtitle 7A. Emergency Use [Auto–Injectable] Epinephrine Program. 20
13–7A–01. 21
(a) In this subtitle the following words have the meanings indicated. 22
(b) “Agent” means an individual who: 23
(1) Is at least 18 years of age; 24
(2) Has successfully completed, at the expense of the participating facility, 25
an educational training program approved by the Department under § 13–7A–03 of this 26
subtitle; and 27
(3) Is designated by a certificate holder to administer [auto–injectable] 28
EMERGENCY U SE epinephrine in accordance with the provisions of this subtitle. 29
(c) “Anaphylaxis” means a sudden, severe, and potentially life–threatening 30
allergic reaction that occurs when an individual is exposed to an allergen. 31
SENATE BILL 459 9
[(d) “Auto–injectable epinephrine” means a portable, disposable drug delivery 1
device that contains a premeasured single dose of epinephrine that is used to treat 2
anaphylaxis in an emergency situation.] 3
[(e)] (D) “Certificate” means a certificate issued by the Department to an 4
individual to obtain, store, and administer [auto–injectable] EMERGENCY USE 5
epinephrine. 6
[(f)] (E) “Certificate holder” means an individual who is authorized by the 7
Department to obtain, store, and administer [auto–injectable] EMERGENCY USE 8
epinephrine to be used in an emergency situation. 9
[(g)] (F) “Eligible institution” means an institution of higher education that has 10
a food service facility or a recreation and wellness facility on the premises and that is 11
authorized under this subtitle to obtain and store [auto–injectable] EMERGENCY USE 12
epinephrine. 13
(G) “EMERGENCY USE EPINEPH RINE” MEANS A PORTABLE , DISPOSABLE 14
DRUG DELIVERY DEVICE OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 15
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 16
EPINEPHRINE THAT IS USED TO TREAT ANAPHYLAXIS IN AN EMERGENCY SITU ATION. 17
(h) “Food service facility” has the meaning indicated in § 21–301 of this article. 18
(i) “Participating facility” means a recreation or wellness facility at an eligible 19
institution or a food service facility, including a food service facility at an eligible 20
institution, in the State that voluntarily participates in the Program. 21
(j) “Program” means the Emergency Use [Auto–Injectable] Epinephrine 22
Program established under § 13–7A–02 of this subtitle. 23
13–7A–02. 24
(a) There is an Emergency Use [Auto–Injectable] Epinephrine Program. 25
(b) The purpose of the Program is to authorize individuals employed by a 26
participating facility to obtain and store [auto–injectable] EMERGENCY USE epinephrine 27
and administer [auto–injectable] EMERGENCY USE epinephrine to individuals who are 28
experiencing or are believed to be experiencing anaphylaxis when a physician or emergency 29
medical services are not immediately available. 30
(c) (1) Subject to paragraph (4) of this subsection, each participating facility 31
may obtain: 32
10 SENATE BILL 459
(i) A prescription for a supply of [auto–injectable] EMERGENCY 1
USE epinephrine from a licensed physician as provided in § 13–7A–06 of this subtitle; and 2
(ii) A supply of [auto–injectable] EMERGENCY USE epinephrine 3
from a licensed pharmacist or a licensed physician as provided in § 13–7A–06 of this 4
subtitle. 5
(2) Each participating facility shall store a supply of [auto–injectable] 6
EMERGENCY USE epinephrine obtained under paragraph (1)(ii) of this subsection: 7
(i) In accordance with the manufacturer’s instructions; and 8
(ii) In a location that is readily accessible to employees or affiliated 9
individuals in an emergency situation. 10
(3) Each participating facility shall designate the employees who are 11
certificate holders or designated affiliated individuals who are certificate holders who will 12
be responsible for the storage, maintenance, and control of the supply of [auto–injectable] 13
EMERGENCY USE epinephrine. 14
(4) A participating facility may not obtain or store [auto–injectable] 15
EMERGENCY USE epinephrine unless the participating facility has at least two employees 16
or designated affiliated individuals who are certificate holders. 17
(5) Each participating facility shall maintain a copy of the certificate issued 18
to an employee or a designated affiliated individual under § 13–7A–05 of this subtitle. 19
13–7A–03. 20
(a) The Department shall: 21
(5) Develop a method by which certificate holders may submit a report to 22
the Department about each incident that occurred on the premises of a participating facility 23
that involved the administration of [auto–injectable] EMERGENCY USE epinephrine by a 24
certificate holder or an agent; and 25
13–7A–06. 26
(a) (1) A physician licensed to practice medicine in the State may prescribe 27
[auto–injectable] EMERGENCY USE epinephrine in the name of a certificate holder. 28
(2) A pharmacist licensed to practice pharmacy in the State or a physician 29
may dispense [auto–injectable] EMERGENCY USE epinephrine under a prescription issued 30
to a certificate holder. 31
(b) A certificate holder may: 32 SENATE BILL 459 11
(1) On presentment of a certificate, receive from any physician licensed to 1
practice medicine in the State a prescription for [auto–injectable] EMERGENCY USE 2
epinephrine and the necessary paraphernalia for the administration of [auto–injectable] 3
EMERGENCY USE epinephrine; and 4
(2) Possess and store prescribed [auto–injectable] EMERGENCY USE 5
epinephrine and the necessary paraphernalia for the administration of [auto–injectable] 6
EMERGENCY USE epinephrine. 7
(c) In an emergency situation when a physician or emergency medical services 8
are not immediately available, a certificate holder or an agent may administer 9
[auto–injectable] EMERGENCY USE epinephrine to an individual who is experiencing or is 10
believed in good faith by the certificate holder or agent to be experiencing anaphylaxis. 11
13–7A–07. 12
(a) (1) Except as provided in paragraph (2) of this subsection, a cause of action 13
may not arise against a certificate holder for any act or omission if the certificate holder or 14
agent is acting in good faith while administering [auto–injectable] EMERGENCY USE 15
epinephrine to an individual who is experiencing or believed by the certificate holder or 16
agent to be experiencing anaphylaxis except where the conduct of the certificate holder or 17
agent amounts to gross negligence, willful or wanton misconduct, or intentionally tortious 18
conduct. 19
(2) The provisions of paragraph (1) of this subsection do not apply if a 20
certificate holder or participating facility that makes available, or a certificate holder who 21
administers, [auto–injectable] EMERGENCY USE epinephrine to an individual who is 22
experiencing or is believed by the certificate holder or participating facility to be 23
experiencing anaphylaxis: 24
(i) Fails to follow standards and procedures for storage and 25
administration of [auto–injectable] EMERGENCY USE epinephrine; or 26
(ii) Administers [auto–injectable] EMERGENCY USE epinephrine 27
that is beyond the manufacturer’s expiration date. 28
(b) (1) A cause of action may not arise against any physician for any act or 29
omission if the physician in good faith prescribes or dispenses [auto–injectable] 30
EMERGENCY USE epinephrine and the necessary paraphernalia for the administration of 31
[auto–injectable] EMERGENCY USE epinephrine to a certificate holder or participating 32
facility under this subtitle. 33
(2) A cause of action may not arise against any pharmacist for any act or 34
omission if the pharmacist in good faith dispenses [auto–injectable] EMERGENCY USE 35
epinephrine and the necessary paraphernalia for the administration of [auto–injectable] 36 12 SENATE BILL 459
EMERGENCY USE epinephrine to a certificate holder or a participating facility under this 1
subtitle. 2
13–7A–08. 3
(b) An individual may not be held civilly liable in any action arising from or in 4
connection with the administration of [auto–injectable] EMERGENCY USE epinephrine by 5
the individual solely because the individual did not possess a certificate issued under this 6
subtitle. 7
13–7A–09. 8
A certificate holder shall submit to the Department, in the manner required under § 9
13–7A–03 of this subtitle, a report of each incident that occurred on the premises of a 10
participating facility that involved the administration of [auto–injectable] EMERGENCY 11
USE epinephrine by a certificate holder or an agent. 12
Article – Health Occupations 13
14–5F–01. 14
(a) In this subtitle the following words have the meanings indicated. 15
[(c) “Auto–injectable epinephrine” means a portable, disposable drug delivery 16
device that contains a premeasured single dose of epinephrine that is used to treat 17
anaphylaxis in an emergency situation.] 18
[(d)] (C) “Board” means the State Board of Physicians. 19
[(e)] (D) “Committee” means the Naturopathic Medicine Advisory Committee. 20
[(f)] (E) “Council” means the Naturopathic Doctors Formulary Council. 21
[(g)] (F) (1) “Device” means a device used in the diagnosis, treatment, or 22
prevention of disease. 23
(2) “Device” does not include: 24
(i) Any surgical or dental instrument; 25
(ii) Any physical therapy equipment; 26
(iii) Any X–ray apparatus; or 27
(iv) Any component part or accessory of any of the items listed in 28
items (i) through (iii) of this paragraph. 29 SENATE BILL 459 13
(G) “EMERGENCY USE EPINEPH RINE” MEANS A PORTABLE , DISPOSABLE 1
DRUG DELIVERY DEVICE OR PRODUCT APPROVED BY THE FEDERAL FOOD AND 2
DRUG ADMINISTRATION THAT C ONTAINS A PREMEASURE D SINGLE DOSE OF 3
EPINEPHRINE THAT I S USED TO TREAT ANAP HYLAXIS IN AN EMERGE NCY SITUATION. 4
14–5F–04.1. 5
(a) (1) There is a Naturopathic Doctors Formulary Council within the Board. 6
(d) (1) The formulary adopted by the Board shall include: 7
(i) Nonprescription drugs and devices; 8
(ii) Prescription oxygen and [auto–injectable] EMERGENCY USE 9
epinephrine; and 10
(iii) Prescription diaphragms and cervical caps for contraception. 11
14–5F–14. 12
(a) A license authorizes a licensee, consistent with naturopathic education and 13
training and competence demonstrated by passing the naturopathic physician licensing 14
examination, to: 15
(5) Administer [auto–injectable] EMERGENCY USE epinephrine; 16
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect June 17
1, 2025. 18
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
President of the Senate.
________________________________________________________________________________
Speaker of the House of Delegates.